Synmosa Biopharma Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Synmosa Biopharma Corp with three other
companies in this sector in Taiwan:
Sinphar Pharmaceutical C O., Ltd.
sales of 2.13 billion Taiwanese Dollars [US$72.24 million]
of which 69%
Sagittarius Life Science Corp.
(1.38 billion Taiwanese Dollars [US$46.87 million]
of which 95%
was Non-toxic sector), and
Nang Kuang Pharmaceutical Co., Ltd
(1.55 billion Taiwanese Dollars [US$52.47 million]
of which 100%
was Medice, Medical Instrument, Trade).
Synmosa Biopharma Corp reported sales of 1.87 billion Taiwanese Dollars (US$63.16 million)
December of 2016.
increase of 5.0%
versus 2015, when the company's sales were 1.78 billion Taiwanese Dollars.
Sales at Synmosa Biopharma Corp have increased during each of the previous five years
(and since 2011, sales have increased a total of 101%).